ScholarWorks@Hanyang University: Kim, Sang Heon

Detailed Information

Kim, Sang Heon (김상헌)

COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)

Research Area

Tel 02-2290-8336
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Asthma:26||asthma:16||epidemiology:7||bronchiectasis:7||Cough:5||mortality:5||StevensJohnson syndrome:5||Allergic rhinitis:4||prevalence:4||treatment:4||Tuberculosis:4||interstitial lung disease:4||toxic epidermal necrolysis:4||Air pollution:3||Paragonimiasis:3||Anaphylaxis:3||Antituberculosis drugs:3||hepatitis:3||Severe asthma:3||exhaled nitric oxide:3||polymorphism:3||quality of life:3||Etiology:3||Hepatitis:3||diagnosis:3||Carcinoma:3||chronic obstructive pulmonary disease:3||COPD:3||Adverse drug reaction:3||pulmonary fibrosis:2||questionnaires:2||reference value:2||Aspirinintolerant asthma:2||Druginduced liver injury:2||adverse reactions:2||Antituberculosis treatment:2||Reference equation:2||Mortality:2||airway inflammation:2||Registries:2||risk factors:2||genetic polymorphism:2||Multiple Pulmonary Nodules:2||guideline:2||Atopic dermatitis:2||severe asthma:2||severity:2||COVID19:2||Ectopic:2||IL1Ra:2||Particulate matter:2||sixminute walk test:2||Rheumatoid arthritis:2||Colchicine:2||steroids:2||Elderly:2||Scrub typhus.:2||Aged:2||biologics:2||biomarker:2||Emergency department visit:2||tuberculosis:2||Nitric oxide:2||lung cancer:2||vaccine:2||Allergy:2||Cystic:2||mannitol:2||Exhaled nitric oxide:2||Adult:2||Antitubercular agents:2||Diffusing capacity.:2||천식:2||Korea:2||idiopathic pulmonary fibrosis:2||corticosteroid:2||Leptospirosis:2||Characteristics:2||cough:2||Thymoma.:2||Diskus:2||Lung cancer:2||Genetic polymorphism:2||Tuberculous pleurisy.:2||Polymorphism:2||Lung volume:2||disease severity:2||Turbuhaler:2||Chronic:2||MAPK.:2||pneumonia:2||emergency department:2||Drug Hypersensitivity:2||Prognosis:2||Malignant effusion:2||population:2||Acute exacerbation:2||Massive pleural effusion:2||eosinophils:2||prognosis:2||Bronchiectasis:2||adult:2||exacerbation:2||Humanized:1||Hymenoptera:1||Hypersensitivity syndrome:1||Hypersensitivity syndrome (HSS):1||IL4:1||IL5:1||Idiopathic Pulmonary Fibrosis:1||IgE:1||Immunocompetence:1||Implementation:1||Indoor air:1||Indoor air quality:1||Induced sputum:1||Influenza B virus:1||Inhalant allergen:1||Interleukin10:1||Interstitial lung disease:1||Invasive pulmonary aspergillosis:1||Iron:1||Korean population:1||Korean version of the Cough Symptom Score:1||Leukemia:1||Lung Disease:1||Lung neoplasms:1||Lupus nephritis:1||Lymphocytic:1||Maculopapular eruption:1||Mannitol:1||Methacholine:1||Methods:1||Mexiletine:1||Micronutrients:1||Molecular docking:1||Monoclonal:1||Mycobacterial disease:1||Mycobacterium tuberculosis:1||Nacetyltransferase 2:1||NAT2 genotype:1||NIOX MINO:1||NOA280i:1||Nasal nitric oxide:1||Nationwide Registry:1||Neoplasm metastasis, kidney:1||Never smoker:1||Nitirc oxide:1||Nocardia:1||NonSmall Cell Lung:1||NonSmallCell Lung:1||NonSteroidal:1||Nonsmall Cell Lung:1||Nontuberculosis mycobacterial (NTM) infection:1||Nuclearfactor kappa B:1||Obesity:1||Paint:1||Paraproteinemias:1||Parasitic lung diseases:1||Peak expiratory flow rate:1||Perception:1||Phenotype:1||Plasmacytoma:1||Pleural Effusion:1||Pleural effusion:1||Porous microparticles:1||PositronEmission Tomography:1||Prevalence:1||Prevention &:1||Principal components analysis:1||Pulmonary Atelectasis:1||Pulmonary Eosinophilia:1||Pulmonary delivery:1||Pulmonary tuberculosis:1||Questionnaires:1||RANTES:1||Rapid Response System:1||Real world:1||Recurrence:1||Reference standards:1||Renal insufficiency:1||Republic of Korea:1||Respiratory allergic diseases:1||Respiratory allergy:1||Respiratory failure:1||Rheumatoid:1||Rhinovirus:1||SABA:1||Sarcoidosis:1||Seasons:1||Secondhand smoke:1||Sitedirected mutagenesis:1||Small Cell Lung Carcinoma:1||Smokers:1||Smoking cessation:1||Solitary fibrous tumor of pleura:1||Sputum:1||Staphylococcus aureus:1||StevensJohnson Syndrome:1||StevensJohnson syndrome (SJS):1||Stomach Neoplasms:1||Sudden:1||Surveys:1||Surveys and questionnaires:1||Symbicort (R) maintenance and reliever therapy:1||Systemic lupus erythematosus:1||Th1 inflammation:1||Th2 responses:1||Thorax:1||Tolllike receptor4:1||Toxic epidermal necrolysis (TEN):1||Transforming growth factor beta1:1||Tumor Necrosis Factoralpha:1||Tumor necrosis factoralpha:1||Upper Extremity Deep Vein Thrombosis:1||Wnt/betacatenin pathway:1||Wnt7a:1||Yellow dust:1||acute exacerbation:1||acute exacerbations of COPD:1||adipokines:1||adiposederived hormones:1||adiposity:1||adults:1||adverse drug events:1||adverse drug reactions:1||adverse reaction:1||age:1||aged:1||air pollution:1||allergens:1||allergic rhinitis:1||allopurinol:1||animal model:1||antiTB drug:1||antituberculosis drugs:1||antibody:1||antioxidation:1||antituberculosis drugs:1||artificial intelligence:1||asthma exacerbation:1||asthmachronic obstructive pulmonary disease overlap syndrome:1||atopy:1||bibliometrics:1||bleomycin:1||body mass index:1||bronchial hyperresponsiveness:1||bronchial provocation test:1||budesonide:1||burden:1||carbonic anhydrase inhibitor:1||chest CT:1||chronic cough:1||chronic disease:1||chronic obstructive pulmonary disease (COPD):1||cigarette smoking:1||cleaved ccn1:1||clinical epidemiology:1||cohort study:1||control:1||cooking:1||coronavirus disease 2019:1||cost:1||cost of illness:1||crosssectional studies:1||death:1||dendritic cells:1||dermatomyositis:1||diagnostic test:1||direct medical cost:1||disease burden:1||disease exacerbation:1||doublestranded RNA:1||druginduced hypersensitivity syndrome:1||drugmetabolizing enzyme:1||economic:1||energy ratio:1||enterotoxins:1||environmental pollution:1||eosinophil:1||eosinophilic bronchitis:1||eruption:1||evidencebased medicine:1||expert opinion:1||financial:1||fishes:1||forced expiratory flow between 25% and 75% of vital capacity:1||formoterol:1||fractional exhaled nitric oxide:1||fulllength CCN1:1||gastroesophageal reflux:1||gender:1||genetic association study:1||genomewide association study:1||health status:1||healthcare workers:1||human leukocyte antigen:1||human leukocyte antigen class I:1||hypersensitivity:1||immunoglobulin E:1||indoor:1||infection:1||inflammatory myopathy:1||influenza:1||inhaled corticosteroid:1||inhaled corticosteroids:1||inhaler:1||intensive care units:1||internal medicine:1||isoniazid monotherapy:1||lipocalin2:1||long shortterm memory:1||loudness:1||lung function tests:1||machinelearning:1||management:1||matrix metalloproteinase1:1||meat:1||medication safety:1||metered dose inhaler:1||metereddose inhaler:1||methacholine:1||methazolamide:1||microtubules:1||multicenter study:1||multiplex polymerase chain reaction:1||multisystem inflammatory syndrome:1||myositis:1||nasal nitric oxide:1||nasal polyps:1||nitric oxide:1||nitric oxide analyzer:1||nonsmall cell lung cancer (NSCLC):1||nontuberculosis mycobacterium:1||obesity:1||outcome:1||oxidation:1||oxidative stress:1||particulate matter:1||peptide:1||perception:1||phage display:1||pharmacoepidemiology:1||pharmacogenomics:1||phenotype:1||phytophthora blight:1||phytophthora capsici:1||point prevalence:1||pollution:1||polygammaglutamic acid:1||polymyositis:1||position paper:1||prescription:1||prescription drug overuse:1||prescription patterns:1||prolonged cough:1||prostaglandin E2:1||public health:1||pulmonary:1||reference values:1||registries:1||registry:1||residents:1||respiratory failure:1||respiratory virus:1||rheumatic diseases (RDs):1||rheumatoid arthritis (RA):1||risk:1||risk factor:1||safety:1||sedentary behavior:1||sensitivity:1||serious outcomes:1||serositis:1||sex:1||siRNA:1||single nucleotide polymorphism:1||single nucleotide polymorphisms:1||sinusitis:1||small cell lung cancer (SCLC):1||smoking:1||specificity:1||steroid:1||superoxide dismutase:1||survival:1||symptom assessment:1||symptom burden:1||symptom exacerbations:1||systematic review:1||thioredoxin reductase 1:1||treatment outcome:1||trigger tool:1||tuberculosis (TB):1||tumour necrosis factora:1||upper airway cough syndrome:1||vaccination:1||virusassociated asthma:1||vitamin C (Lascorbic acid):1||간염:1||개회충증:1||결핵:1||과호산구증가증:1||급성 악화:1||기도염증:1||대기오염:1||류마티스관절염:1||약물 이상반응:1||응급실방문:1||항결핵제:1||호기산화질소:1||15lipoxygenase:1||호산구증가증:1||A549 cell:1||ATPbinding cassette C2:1||Abnormalities:1||Acute kidney injury:1||Acute respiratory failure:1||Adenosine deaminase:1||Adenosine receptors:1||Adverse cutaneous reactions:1||Adverse drug event:1||Adverse drug reactions:1||Aggressive:1||Air:1||Airway hyperresponsiveness:1||Allergist:1||Allopurinol:1||Analysis:1||AntiInflammatory Agents:1||AntiTB drugs:1||Antibodies:1||Antiepileptic drugs:1||Antifibrotic Agent:1||Antiphospholipid Syndrome:1||Antituberculosis drug:1||Apitherapy:1||Aptamin C (vitamin C binding Aptamer):1||Arthritis:1||AtRisk Patient:1||Atopy:1||BCell:1||Bee venoms:1||Biliary fistula:1||Biologic Markers:1||Biological products:1||Bronchi:1||Bronchial arteries:1||Bronchial hyperreactivity:1||Bronchial provocation tests:1||Bronchoalveolar lavage:1||Bronchopleural fistula:1||Budesonide:1||COPD treatment:1||COVID19 infection:1||Cancer screening:1||Carbamazepine:1||Carcinoma, squamous cell:1||Cardiac:1||Cardiovascular diseases:1||Caseinolytic protease C1:1||ChAdOx1 nCoV19 vaccine:1||Chest Tubes:1||Chronic Obstructive Pulmonary Disease:1||Chronic cough:1||Chronic disease:1||Chronic expanding hematoma:1||Chronic obstructive pulmonary disease:1||Climate change:1||Clinical characteristics:1||Cohort:1||Contrast media:1||Corticosteroids:1||Cutaneous infection:1||Cystic adenomatoid malformation of lung, Congenital:1||Death:1||Dental Technicians:1||Diagnostic techniques and procedures:1||Disease prevention:1||Disease progression:1||Disease susceptibility:1||Drainage:1||Drug:1||Drug eruption:1||Drug hypersensitivity:1||Drug hypersensitivity syndrome:1||Drug transporter:1||Drugmetabolizing enzymes:1||Drugrelated side effects and adverse reactions:1||Ecadherin:1||EP receptor:1||Ecumicin:1||Education:1||Embolism:1||Embolization, therapeutic:1||Excerbation:1||Exercise:1||Exercise test:1||Extended RRS:1||FDG PET:1||Fas signaling pathway:1||Fat embolism syndrome:1||Fat globules:1||Fibromatosis:1||Generalized edema:1||Genetic association:1||Geographic locations:1||Glutathione Stransferase enzyme:1||Guideline:1||HLAB*58:01 allele:1||Hemoptysis:1||Hepatotoxicity:1||Histology:1||Human leukocyte antigen:1||Human leukocyte antigen (HLA):1||

STATISTICS: Total View :4,997,351; Today View :3,921

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE